MilliporeSigma and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry

MilliporeSigma and Schneider Electric combine capabilities to automate biopharmaceutical process Customers would save time, get greater flexibility with automated solution Shanghai, China, March 5, 2018 — MilliporeSigma, a leading science and technology company, and Schneider Electric, a global specialist in energy management and automation, announced the signing of a Memorandum of Understanding (MoU) that aims to automate... Read more

MilliporeSigma Furthers Scientists’ Research Through Expanded Seeding Labs Partnership

News Release February 28, 2018 Your Contact: Karen Tiano +1 978 495 0093 MilliporeSigma Furthers Scientists’ Research Through Expanded Seeding Labs Partnership New TeleScience online platform provides teaching and training to scientists in developing countries Burlington, Massachusetts, February 28, 2018 — MilliporeSigma today announced an expansion of its partnership with Seeding Labs to accelerate teaching and research for... Read more

MilliporeSigma Introduces Stericup® Quick Release System for Improved Cell Culture Filtration

Optimizes user control and streamlines filtration process Uses quality-tested Millipore® membranes for reliable performance Burlington, Massachusetts, November 13, 2017 — MilliporeSigma today launched the new Stericup® Quick Release 500 mL vacuum filtration system, a filter bottle system ideally suited for sterile filtration of cell culture media, buffers and reagents. The Stericup® Quick Release system is the next generation... Read more

Canadian Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology

News Release October 23, 2017 Your Contact: Karen Tiano +1 978 495 0093 Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR First patent allowance for MilliporeSigma’s CRISPR technology in North America Related patent application awards by European and Australian Patent Offices already received; similar patents pending... Read more